Case reportPublished 14 Mar 2024
Patient with a Pituitary Adenoma Haemorrhage and Total Ophtalmophlegie under Treatment with ASS and Plavix as a Secondary Stroke Prophylaxis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In our case report, we discuss a patient, who underwent a dual antiplatelet therapy as a secondary prevention of stroke. To our knowledge, there are no other cases in the literature reviews about pituitary haemorrhage on dual antiplatetelet therapy. The 7th most common reason for intrapituitary haemorrhage is aspirin. However, the risk for bleeding was not considered when a dual therapy was administered. The patients, who have suffered a stroke, need a suitable secondary stroke prophylaxis. The dual therapy has shown advantages over the monotherapy with aspirin or with clopidogrel. The personal approach to every patient, who has suffered a stroke, has to be taken. The pituitary adenoma can increase the risk for intracranial bleeding, when a dual therapy is used as a second stroke prophylaxis.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Orlin Pavlov”
- BylineArticles whose byline prints “Mirchev Nikolay”
- BylineArticles whose byline prints “Obersheimer Jens”
- BylineArticles whose byline prints “Behr Robert”
